1. Introduction {#sec1}
===============

Specifications TableSubjectPharmaceutical ScienceSpecific subject areaInterdisciplinary field includes organic chemistry, biochemistry, and biology. Drug design and discovery from plant sources.Type of dataTables\
FiguresHow data were acquiredSchrodinger Maestro release 2018-4Data formatRaw and AnalysedParameters for data collectionThe docking score, glide energy and interactions of protein with the ligand.Description of data collectionThe Proteins were collected from rcsb wwPDB. The flavonoids structures were obtained from Pubchem online database. The docking was done using glide software.Data source location<https://www.rcsb.org/>\
<https://pubchem.ncbi.nlm.nih.gov/>Data accessibilityPDB files of the chosen enzyme targets are publically available at <https://www.rcsb.org/>\
Tables and Figures of the docking are accessible in the article.**Value of the Data**•The screening procedure enable the researchers to rapidly identify active natural compounds which can modulate a particular biochemical pathway.•The screening results help to study the interaction/role of a bioactive flavonoid in a particular biochemical process at cellular level and provide preliminary ideas for drug design development•By using this *in-silico* docking data, novel synthetic analogues with improved bioactivity and minimized side effects can be developed against these targets and research time can be minimized considerably.•We select these 26 flavonoids because these are abundant in nature and well explored. Among these 26 flavonoids, the compounds which shows best affinity for various targets are shortlisted.•The data also useful for research scholars who does not have the sufficient software and hardware requirements which not affordable by them.•Research scholars, researchers in pharmaceutical chemistry can be benefit from the data.Flavonoids are a group of bioactive compounds which are extensively found in foodstuffs of plant origin. These are plant pigments synthesized from phenylalanine and generally display marvelous colors to the flowering parts of plants. Flavonoids comprise a large group of poly phenolic compounds, characterized by a benzo-4-pyrone structure, which is ubiquitous in vegetables and fruits. More than 9000 flavonoids have been reported in the literature and are present in different types and parts of plants such as vegetables, fruits, grains, legumes, beans, herbs, roots, leaves, seeds etc. The core structure of flavonoids has a three-ring diphenyl-propane (C6--C3--C6) unit, a fifteen-carbon skeleton. The flavonoid contains two benzene rings (A ring and B ring) which are connected by a C3 moiety. The C3 moiety forms a six-membered heterocyclic ring (ring C) attached to ring A. Regular consumption of flavonoids reduces the risk of a number of chronic diseases, including cancer, cardiovascular disease, diabetes, arthrosclerosis, neurodegenerative disorders, anti-ageing, anti-inflammatory, antiallergic, antiviral, and free radical scavenging. Among dietary sources of flavonoids, there are fruits, vegetables, nuts, seeds and spices. So, the provided docking data of flavonoid may be useful to synthesis novel drug candidate for the mentioned targets.Image 1

2. Data {#sec2}
=======

In this article [Table 1](#tbl1){ref-type="table"} provides the details about the targets and their description. [Table 2](#tbl2){ref-type="table"} provide the structure of the naturally occurring flavonoids and plant sources. [Table 3](#tbl3){ref-type="table"} gives docking score, glide energy, interaction type and bond length of the docking. The 3D and 2D interactions of the high scored flavonoids with the target enzymes are shown in [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"}, [Fig. 7](#fig7){ref-type="fig"}.Table 1**List of Targets**. Shows the PDB ID, resolution and description of the proteins selected for docking with the naturally occurring flavonoids.Table 1S.NoPDB IDResolution (Å)Description13LN02.20Structure of compound 5c-S bound at the active site of COX-2 \[[@bib1]\]24KIK2.83Human IkB kinase beta \[[@bib2]\]32XCS2.10The crystal structure of *Staphylococcus aureus* Gyrase complex with GSK299423 and DNA \[[@bib3]\]44HZ52.70Pyrrolopyrimidine inhibitors of DNA gyrase b and topoisomerase iv, part i: structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity \[[@bib4]\]54RLJ1.75Crystal Structure of (3R)-hydroxyacyl-ACP dehydratase HadAB hetero-dimer from *Mycobacterium tuberculosis* \[[@bib5]\]61IYL3.20Crystal Structure of *Candida albicans* N-myristoyltransferase with Non-peptidic Inhibitor \[[@bib6]\]71LRY2.60Crystal Structure of *Pseudomonas aeruginosa* Peptide Deformylase Complexed with Antibiotic Actinonin \[[@bib7]\]82AIE1.70*Streptococcus pneumoniae* polypeptide deformylase complexed with inhibitor \[[@bib7]\]92Y9X2.78Crystal structure of PPO3, a tyrosinase from *Agaricus bisporus*, in deoxy-form that contains additional unknown lectin-like subunit, with inhibitor tropolone \[[@bib8]\]103A4A1.60Crystal structure of isomaltase from *Saccharomyces cerevisiae* \[[@bib9]\]116FFC3.56Structure of an inhibitor-bound human ABC transporter \[[@bib10]\]Table 2**List of Flavonoids**. This table exemplifies the plant sources of the naturally occurring flavonoids, so that the compounds may be isolated and used for the research purposes.Table 2S.NoName of the flavonoidMajor plant sourceStructure1Dabinol*Dalbergia latifolia*![](fx2.gif)25HMF*Citrus X sinensis*![](fx3.gif)36a,12a-Dehydroamorphigenin*Dalbergia sissoo*![](fx4.gif)4Afromosin*Centrosema pubescens*![](fx5.gif)5Amorphigenin*Dalbergia cochinchinensis*![](fx6.gif)6Biochanin- A*fusarium javanicum*![](fx7.gif)7Catechin*Camelia sinensis*![](fx8.gif)8Chrysin*Scutellaria baicalensis*![](fx9.gif)9Demethylnobiletin*Citrus depressa*![](fx10.gif)10Epicatechingallate (ECG)*Vicia faba*![](fx11.gif)11Epigallocatechin*Camellia sinensis*![](fx12.gif)12Epigallocatechingallate (EGCG)*Camellia sinensis*![](fx13.gif)13Floretin (Phloretin)*Manchurian apricot.*![](fx14.gif)14Formononetin*Trifolium pratense*![](fx15.gif)15Hesperidin*Citrus aurantium*![](fx16.gif)16Morin*Antiaris toxicaria*![](fx17.gif)17Naringenin*Citrus paradisi*![](fx18.gif)18Naringin*Citrus paradisi*![](fx19.gif)19Neohesperidin*citrus aurantium*![](fx20.gif)20Quercetin*Malus domestica*![](fx21.gif)21Robinin*Vinca erecta*![](fx22.gif)22Rotenone*Pachyrhizus erosus*![](fx23.gif)23Sakuranetin*Polymnia fruticosa*![](fx24.gif)24Silymarin*Silybum marianum*![](fx25.gif)25Nobiletin*Citrus Unshiu*![](fx26.gif)26Kaempferol*Allium cepa*![](fx27.gif)Table 3**Docking score, Glide energy and Protein-Ligand Interactions**. The docking score, Glide energy, interacting residues, type of interactions, bond length between residues and ligands are shown for each protein mentioned in [Table 1](#tbl1){ref-type="table"}.Table 3TitleDocking\
ScoreGlide\
Energy\
(Kcal/mol)InteractionsTypeBond length (Å)**Protein ID: 2XCS Antibacterial by gyrase inhibition**Robinin−8.03−84.11Asp A:1083\
Asp A:1080\
Glu A:1088\
Arg A:1122H-bond\
Ar-H-bond\
2 H-bond\
2 H-bond2.03\
2.20\
1.73, 1.93\
2.17, 2.61Naringin−7.85−62.60Lys 581\
Asp 1083H-bond\
Ar-H-bond2.43\
2.63Neohesperidin−7.72−70.99Asp 1083H-bond1.90Silymorin−7.29−44.08Glu 1088\
Ala 1120\
Tyr 1087H-bond\
H-bond\
Ar-H-bond2.04\
2.17\
2.70Hesperidin−7.25−68.40Arg 1122H-bond2.29**Protein ID: 4KIK Anticancer by IkB kinase inhibition**Sakuranetin−9.73−44.98Asp A:166\
Glu A:97\
Cys A:99H-bond\
H-bond\
H-bond1.45\
2.40\
2.04Naringenin−9.53−43.50Glu A:97\
Cys A:99\
Asp A:166H-bond\
H-bond\
H-bond2.42\
2.04\
1.45Kaempferol−9.33−45.40Lys A:44\
Asp A:166\
Cys A:99H-bond\
H-bond\
H-bond2.04\
2.16\
2.02Naringin−9.07−59.59Asp A:145\
Lys A:147\
Asp A:166\
Glu A:97\
Glu A:97\
Cys A:99H-bond\
H-bond\
H-bond\
H-bond\
Ar-H-bond\
H-bond1.78\
2.22\
1.87\
1.87\
2.48\
2.07Morin−9.03−46.84Asp A:166\
Lys A:44\
Cys A:99H-bond\
H-bond\
H-bond2.09\
2.02\
2.01**Protein ID: 4HZ5 Antibacterial by DNA gyrase b and topoisomerase IV inhibition**Phloretin−7.06−50.83Asp 26\
HOH 407\
HOH 408\
HOH 401H-bond\
H-bond\
H-bond\
H-bond1.87\
2.77\
1.77\
2.95Catechin−6.93−45.78Gly 80\
Asp 76\
HOH 427H-bond\
H-bond\
H-bond2.38\
1.78\
1.64Morin−6.92−51.77Asp 76\
Asp 76\
Gly 80H-bond\
Ar-H-bond\
H-bond1.59\
2.36\
2.45Kaempferol−6.75−47.93Gly 80\
Asp 76Ar-H-bond\
H-bond2.40\
1.60Sakuranetin−6.49−41.60Asp 76\
Gly 80\
HOH 401H-bond\
H-bond\
H-bond1.81\
2.69\
2.12**Protein ID: 2Y9X Antifungal (*Agaricus bisporus*) by tyrosinase inhibition**Epigallocatechingallate−7.22−51.13Arg 268\
Asn 260\
Phe 264Pi-cation\
Ar-H-Bond\
Ar-H-Bond6.02\
2.66\
3.12Chrysin−7.20−34.87His 259\
Hid 85Ar-H-Bond\
Ar-H-Bond3.63\
3.25Kaempferol−7.02−35.15Hie 244\
Arg 268Ar-H-Bond\
Pi-cation3.02\
5.66Quercetin−6.75−34.47Asn 260\
Arg 268Ar-H-Bond\
Pi-cation2.77\
2.89Catechin−6.67−32.30Arg 268Pi-cation6.19**Protein ID: 3LN0 Anti-inflammatory by cyclo-oxygenase inhibition**Sakuranetin−7.31−31.36Ser 516H-Bond2.67Quercetin−7.00−34.33Try 371\
Try 371\
Gly 178Ar-H-Bond\
H-Bond\
H-Bond3.08\
2.72\
2.71Naringenin−6.99−30.27Ser 516H-Bond2.62Morin−6.98−35.14Try 371\
His 75\
Tyr 341\
Arg 106H-Bond\
Ar-H-Bond\
Ar-H-Bond\
Pi-cation2.38\
3.00\
2.51\
7.60Kaempferol−6.91−33.28Tyr 371\
Tyr 371Ar-H-Bond\
H-Bond3.50\
2.24**Protein ID: 4RLJ Antituberculosis (*Mycobacterium tuberculosis*) by hydroxyacyl-ACP dehydratase inhibition**Catechin−7.47−39.00HOH 322\
HOH 312H-Bond\
H-Bond1.84\
2.14Biochanin A−6.95−32.44Gln 86\
HOH 322Ar-H-Bond\
H-Bond2.63\
1.73Quercetin−6.76−39.63HOH 322H-Bond1.88Chrysin−6.60−32.57Gln 86\
Gln 86\
HOH 387H-Bond\
Ar-H-Bond\
Ar-H-Bond2.65\
2.48\
2.27Formononetin−6.47−31.39Gln 86\
HOH 322Ar-H-Bond\
Ar-H-Bond2.84\
2.61**Protein ID: 6FFC Inhibition capacity of human multidrug transporter ABCG2**Robinin−7.14−53.99Phe 439\
Asn 436\
Thr 402\
Thr 435\
Gln 368H-Bond\
Ar-H-Bond\
Ar-H-Bond\
H-Bond\
H-Bond1.85\
2.22\
2.57\
2.11\
2.40Morin−6.64−34.48Thr 402\
Phe 489\
Asn 436H-Bond\
Ar-H-Bond\
H-Bond1.68\
3.44\
1.78Phloretin−6.39−34.84Asn 436\
Phe 489\
Thr 402H-Bond\
Ar-H-Bond\
Ar-H-Bond1.86\
3.64\
2.56Catechin−6.36−32.35Thr 402\
Phe 489\
Phe 489\
Asn 436\
Asn 436H-Bond\
Ar-H-Bond\
H-Bond\
Ar-H-Bond\
H-Bond1.85\
3.23\
1.38\
2.22\
2.20Phloretin−6.36−35.65Thr 402\
Phe 489\
Asn 436Ar-H-Bond\
Ar-H-Bond\
H-Bond2.69\
3.63\
1.83**Protein ID: 3A4A Antifungal (*Saccharomyces cerevisiae*) by isomaltase inhibition**Epigallocatechin−6.98−44.31Glu 411\
Tyr 158\
Tyr 158\
Phe 314\
Phe 314\
Asp 307\
Asp 307H-Bond\
Ar-H-Bond\
H-Bond\
Ar-H-Bond\
H-Bond H-Bond\
Ar-H-Bond1.76\
2.95\
2.92\
3.12\
3.51\
1.46\
2.60Morin−6.50−40.65Asp 307\
Gln 353\
HOH 1207H-Bond\
HBond Ar-H-Bond1.69\
1.79\
2.46Chrysin−5.61−34.69Glu 411\
Tyr 158\
Gln 353\
Asp 307Ar-H-Bond\
H-Bond\
Ar-H-Bond\
Ar-H-Bond2.79\
1.92\
2.35\
2.25Morin−5.31−38.38Tyr 158\
Tyr 158\
Asp 307\
Gln 353\
Gln 353Ar-H-Bond\
H-Bond\
Ar-H-Bond\
Ar-H-Bond\
H-Bond2.78\
1.73\
2.50\
2.56\
1.80Phloretin−4.64−38.76Glu 411\
Asn 415\
Gln 353H-Bond\
H-Bond\
H-Bond2.43\
2.19\
2.10**Protein ID: 1IYL Antifungal (*Candida albicans*) by N-myristoyltransferase inhibition**Epigallocatechingallate−8.59−58.16Glu 109\
Phe 339\
Phe 115\
Asn 392\
Tyr 225\
Tyr 356\
Leu 451\
Tyr 107Ar-H-bond\
Ar-H-bond\
Pi-Pi\
H-bond\
Pi-Pi\
Ar- H-bond\
2 H-bond\
H-bond3.09\
3.18\
4.39\
2.07\
4.16\
3.69\
2.07, 1.88\
2.60Neohesperidin−8.55−54.56Asn 392\
Tyr 354\
Tyr 335\
Leu 45H-bond\
2 Ar- H-bond\
H-bond\
H-bond1.96\
3.44, 3.64\
2.25\
1.85Biochanin A−8.24−41.78Asn 392\
Hie 227\
Tyr 354\
Tyr 225Ar-H-bond\
H-bond\
2 Pi-Pi\
2 Pi-Pi2.32\
2.19\
4.10, 4.13\
4.11,4.86Formononetin−8.13−38.64Tyr 354\
Tyr 225\
Hie 227\
Asn 3922 Pi-Pi\
2 Pi-Pi\
H-bond\
Ar-H-bond4.10, 4.13\
4.11,4.86\
2.24\
2.33Quercetin−7.91−44.10Tyr 354\
Tyr 225\
Hie 227\
Hie 227\
Glu 109\
Leu 451\
Leu 4502 Pi-Pi\
2 Pi-Pi\
2 H-bond\
Ar-H-bond\
H-bond\
H-bond\
H-bond4.10, 4.13\
4.11,4.86\
2.59, 2.17\
3.19\
2.33\
1.87\
1.87**Protein ID: 1LRY Antibacterial (*Pseudomonas aeruginosa*) by Peptide Deformylase inhibition**Silymarin−8.82−63.36Glu 134\
Ile 144\
Pro 42Ar- H-bond\
H-bond\
H-bond2.53\
1.84\
1.85Epigallocatechin−7.90−53.17Glu 134\
Leu 92\
Ile 44\
Gln 882 H-bond\
H-bond\
H-bond\
H-bond1.55, 1.67\
2.15\
2.36\
1.78Naringenin−7.38−42.98Glu 134\
Glu 134\
Gly 44\
Gly 44\
Tyr 87H-bond\
Ar-H-bond\
H-bond\
Ar-H-bond\
Ar-H-bond1.56\
2.35\
1.69\
2.69\
2.58Quercetin−7.29−48.76Glu 134\
Glu 134\
Gln 88H-bond\
Ar-H-bond\
H-bond1.67\
2.48\
1.76Neohesperidin−7.28−60.23Glu 134H-bond1.56**Protein ID: 2AIE Antibacterial (*Streptococcus pneumoniae*) by polypeptide deformylase inhibition**Epigallocatechin−6.40−46.08Gly 68\
Leu 131\
Glu 174H-bond\
H-bond\
2 H-bond1.70\
2.21\
1.64, 2.03Catechin−6.21−44.36Gly 68\
Leu 131\
Glu 174\
Glu 174Ar- H-bond\
H-bond\
H-bond\
Ar-H-bond2.42\
2.54\
1.77\
2.35Robinin−6.12−64.85Glu 125\
Arg 67\
Glu 174H-bond\
H-bond\
2 H-bond1.68\
2.07\
1.50, 1.78Hesperidin−5.93−52.09Glu 125\
Arg 67H-bond\
Pi-cation1.60\
5.98Epigallocatechingallate−5.88−56.62Gly 68\
Glu 174H-bond\
2 H-bond1.77\
1.92, 1.65Fig. 1**3D and 2D interactions of COX-2 (PDB ID: 3LN0) with flavonoid Sakuranetin**. Figure shows Sakuranetin binding and interactions with human cyclo-oxygenase-2 with docking score of −7.31.Fig. 1Fig. 2**3D and 2D interactions of Human Ikb Kinase Beta (PDB ID: 4KIK) with flavonoid Sakuranetin**. Figure shows Sakuranetin binding and interactions with Human Ikb Kinase Beta with docking score of −9.73.Fig. 2Fig. 3**3D and 2D interactions of DNA gyrase (PDB ID: 2XCS) with Flavonoid Robinin**. Figure shows Robinin binding and interactions with DNA gyrase *Staphylococcus aureus* with docking score of −8.03.Fig. 3Fig. 4**3D and 2D interactions of tyrosinase (PDB ID: 2Y9X) with flavonoid Epigallocatechingallate**. Figure shows Epigallocatechingallate binding and interactions with *Agaricus bisporus* tyrosinase with docking score of −7.22.Fig. 4Fig. 5**3D and 2D interactions of DNA gyrase (PDB ID: 4HZ5) with flavonoid Phloretin**. Figure shows Phloretin binding and interactions with DNA gyrase with docking score of −7.06.Fig. 5Fig. 6**3D and 2D interactions of Isomaltase (PDB ID: 34A4) with flavonoid Epigallocatechin**. Figure shows Epigallocatechin binding and interactions with Isomaltase of *Saccharomyces cerevisiae* with docking score of −6.98.Fig. 6Fig. 7**3D and 2D interactions of ABC transporter (PDB ID: 6FFC) with flavonoid Robinin**. Figure shows Robinin binding and interactions with Human ABC transporter with docking score of −7.14.Fig. 7

3. Experimental design, materials, and methods {#sec3}
==============================================

3.1. Protein selection and preparation {#sec3.1}
--------------------------------------

The crystal structures of the selected proteins were retrieved from protein data bank. (PDB database, [www.rcsb.org](http://www.rcsb.org){#intref0025}). The downloaded protein structure was prepared prior to docking using Schrodinger Maestro release 2018-4. Protein preparation was done by preprocessing the structures by assignment of bonds and bond orders, addition of hydrogens, filling in missing loops or side chains, capping uncapped C and N termini, adjusting bonds and formal charges for metals, and correcting mislabeled elements, removing water molecules, removing unwanted chains and optimization of hydrogen bonded structures followed by minimization.

3.2. Ligand preparation and molecular docking {#sec3.2}
---------------------------------------------

The structures of the selected 26 flavonoids were downloaded from Pubchem <https://pubchem.ncbi.nlm.nih.gov/>) and saved in mol format. The energy minimization was done using Ligprep. The minimized structures were docked on the prepared protein. The best flavonoid was identified based on the binding energy and interaction with amino acid residues for each protein.
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The following are the Supplementary data to this article:Multimedia component 1Multimedia component 1Multimedia component 2Multimedia component 2

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.dib.2020.105243>.
